<style>
.table-wrap{overflow:auto; max-width:100%;}
.segment-pivot { width:100%; border-collapse:collapse; font-family: Arial, sans-serif; font-size:14px; }
.segment-pivot thead th { position:sticky; top:0; background:#fff; z-index:1; border-bottom:1px solid #ddd; }
.segment-pivot th, .segment-pivot td { padding:6px 8px; border-bottom:1px solid #f0f0f0; }
.segment-pivot tbody tr:nth-child(even){ background:#fafafa; }
.segment-pivot td, .segment-pivot th { white-space:nowrap; }
.segment-pivot td { font-variant-numeric: tabular-nums; text-align:right; }
.segment-pivot td:first-child, .segment-pivot th:first-child { text-align:left; }
.table-note { font-size:12px; color:#666; margin:6px 0 8px; }
</style>
<div class="table-note">SEGMENTS v2025-09-09 · 2025-09-05 03:33 UTC — Values are shown in a single scale for this table: <b>$B</b>. TTM values are <b>bold</b>. “% of Total (TTM)” shows revenue mix.</div>
<div class='table-wrap'><table class="dataframe segment-pivot">
  <thead>
    <tr style="text-align: right;">
      <th>Segment</th>
      <th>2022 Rev ($B)</th>
      <th>2022 OI ($B)</th>
      <th>2023 Rev ($B)</th>
      <th>2023 OI ($B)</th>
      <th>2024 Rev ($B)</th>
      <th>2024 OI ($B)</th>
      <th>TTM Rev ($B)</th>
      <th>TTM OI ($B)</th>
      <th>% of Total (TTM)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>S K Y R I Z I Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>9.62B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>238.9%</td>
    </tr>
    <tr>
      <td>R I N V O Q Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>3.64B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>90.5%</td>
    </tr>
    <tr>
      <td>Other Products Member</td>
      <td>4.14B</td>
      <td>0.00B</td>
      <td>3.04B</td>
      <td>0.00B</td>
      <td>3.03B</td>
      <td>0.00B</td>
      <td><strong>2.62B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>65.1%</td>
    </tr>
    <tr>
      <td>Qulipta Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.95B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>23.6%</td>
    </tr>
    <tr>
      <td>Botox Therapeutic Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.69B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>17.2%</td>
    </tr>
    <tr>
      <td>Vraylar Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.65B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>16.0%</td>
    </tr>
    <tr>
      <td>Ubrelvy Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.50B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>12.5%</td>
    </tr>
    <tr>
      <td>Vyalev Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.43B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>10.6%</td>
    </tr>
    <tr>
      <td>Elahere Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.35B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>8.8%</td>
    </tr>
    <tr>
      <td>V E N C L E X T A Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.32B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>7.9%</td>
    </tr>
    <tr>
      <td>Creon Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.13B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>3.3%</td>
    </tr>
    <tr>
      <td>Epkinly Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.13B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>3.2%</td>
    </tr>
    <tr>
      <td>Lumigan Ganfort Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.03B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.7%</td>
    </tr>
    <tr>
      <td>Other Aesthetics Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.03B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.7%</td>
    </tr>
    <tr>
      <td>Other Oncology Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.00B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.1%</td>
    </tr>
    <tr>
      <td>Ozurdex Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.01B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-0.3%</td>
    </tr>
    <tr>
      <td>Other Neuroscience Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.04B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-1.0%</td>
    </tr>
    <tr>
      <td>Alphagan Combigan Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.05B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-1.2%</td>
    </tr>
    <tr>
      <td>M A V Y R E T Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.06B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-1.5%</td>
    </tr>
    <tr>
      <td>Linzess Constella Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.09B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-2.2%</td>
    </tr>
    <tr>
      <td>Duodopa Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.10B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-2.5%</td>
    </tr>
    <tr>
      <td>Other Eye Care Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.11B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-2.7%</td>
    </tr>
    <tr>
      <td>Botox Cosmetic Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.30B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-7.5%</td>
    </tr>
    <tr>
      <td>Imbruvica Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.44B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-11.0%</td>
    </tr>
    <tr>
      <td>Juvederm Collection Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.46B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-11.5%</td>
    </tr>
    <tr>
      <td>H U M I R A Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-14.4B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-357.7%</td>
    </tr>
  </tbody>
</table></div>